3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC
|
|
|
- George Hampton
- 5 years ago
- Views:
Transcription
1 rd 3 party manufacturing PRODUCT LIST Category : ANTI BIOTIC
2 ANTI BIOTIC SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 1 Amikacin Sulphate IP 500mg/2ml DRUG LIQUID INJ. VIAL 2 Amoxicillin 200mg & Clavulanic Acid 28.5mg DRUG DRY SYP 30 ML 3 Amoxicillin-200mg & Clavulanic Acid 28.5mg DRUG DRY SYP 30 ML+WATER 4 Amoxicillin 400mg & Clavulanic Acid 57mg DRUG DRY SYP 30 ML 5 Amoxicillin-400 Mg+Clavulanic Acid-57 Mg DRUG DRY SYP 30 ML+WATER 6 Amoxycillin (250 Mg) + Pot..Clavunate (125 Mg) DRUG TABLET 10X10 ALU-ALU/STRIP 7 Amoxycillin (500 Mg) + Potassium Clavunate (125 Mg) DRUG TABLET 10X10 ALU-ALU/STRIP 8 Amoxycillin -125 DT DRUG TABLET 10X10 ALU-ALU 9 Amoxycillin- 125 Mg /5 Ml DRUG DRY SYP 30 ML 10 Amoxycillin -250 DT DRUG TABLET 10X10 ALU-ALU 11 Amoxycillin -250Mg+ Dicloxacillin-250 Mg DRUG CAPSULE 10X10 ALU-ALU 12 Amoxycillin And Potassium Clavulanate Ip 1.2 G DRUG DRY INJ. VIAL+SWFI 13 Amoxycillin-250 Mg DRUG CAPSULE 10X10 ALU-ALU 14 Amoxycillin-500 Mg DRUG CAPSULE 10X10 BLISTER 15 Ampicillin DRUG DRY SYP 30 ML 16 Azithromycin 200Mg DRUG SYP/SUSP 30ML. 17 Azithromycin 250Mg DRUG TABLET 10X6 BLISTER 18 Azithromycin 250Mg With Lactic Acid DRUG TABLET 10X6 BLISTER 19 Azithromycin 500Mg DRUG TABLET 20X3 BLISTER 20 Azithromycin 500Mg With Lactic Acid DRUG TABLET 20X3 BLISTER 21 Cefepime+Tazobactam 1125Mg DRUG DRY INJ. VIAL+SWFI 22 Cefepime + Tazobactam Mg DRUG DRY INJ. VIAL+SWFI 23 Cefepime + Tazobactam Mg DRUG DRY INJ. VIAL+SWFI 24 Cefepime 1000Mg DRUG DRY INJ. VIAL+SWFI 25 Cefepime 250Mg DRUG DRY INJ. VIAL+SWFI 26 Cefepime 500Mg DRUG DRY INJ. VIAL+SWFI 27 Cefexime 50 Mg+Ofloxacin 50 Mg DRUG DRY SYP30 ML. M.carton 28 Cefexime 50 Mg+Ofloxacin 50 Mg DRUG DRY SYP30 M.carton 29 Cefixime (200 Mg) + Pot..Clavuanate (125 Mg) DRUG TABLET 10X10 ALU ALU STRIP 30 Cefixime 200Mg & Lactic Acid (60 Million) DRUG TABLET 10X10 ALU ALU /STRIP 31 Cefixime 200Mg + Azithromycin 250Mg DRUG TABLET 10X10 ALU-ALU 32 Cefixime 200Mg + Ofloxacin 200Mg DRUG TABLET 10X10 ALU-ALU 33 Cefixime 200Mg +Azithromycin 250Mg+Lactic Acid DRUG TABLET 10X10 ALU-ALU 34 Cefixime 25Mg DRUG DRY SYP 30 ML 35 Cefixime -50 Mg + Ornidazole-125 Mg DRUG DRY SYP 30 ML. M.carton 36 Cefixime-100 Mg DRUG DRY SYP 30 ML 37 Cefixime-100 Mg DRUG TABLET 10X10 ALU-ALU 38 Cefixime-200 Mg DRUG TABLET 10X10 ALU-ALU 39 Cefixime-200 Mg + Ornidazole-500 Mg + Lactic Acid
3 SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING Bacillus-120 Million Sproes+ Saccharomyces Boulardii-2 Million Spores DRUG TABLET 10X10 ALU-ALU 40 Cefixime-50 Mg + Clavulanic Acid Mg DRUG DRY SYP 30 ML 41 Cefixime-50 Mg + Clavulanic Acid Mg DRUG DRY SYP 30 ML WATER 42 Cefixime-50 Mg+Lactic Acid DRUG DRY SYP 30 ML. M.carton 43 Cefixime-50 Mg+Lactic Acid DRUG DRY SYP 30 ML M.carton 44 Cefixime-50Mg DRUG DRY SYP 30 ML 45 Cefixime-50Mg DRUG TABLET 10X10 ALU-ALU 47 Cefoperazone + Sulbactam 1000Mg DRUG DRY INJ. VIAL+SWFI 48 Cefoperazone + Sulbactam 1500Mg DRUG DRY INJ. VIAL+SWFI 49 Cefoperazone + Sulbactam 2000Mg DRUG DRY INJ. VIAL+SWFI 50 Cefoperazone + Sulbactam 3000Mg DRUG DRY INJ. VIAL+SWFI 51 Cefoperazone + Sulbactam 500Mg DRUG DRY INJ. VIAL+SWFI 52 Cefoperazone 1000Mg DRUG DRY INJ. VIAL+SWFI 53 Cefotaxime 1000Mg DRUG DRY INJ. VIAL+SWFI 54 Cefotaxime 250Mg DRUG DRY INJ. VIAL+SWFI 55 Cefotaxime 500Mg DRUG DRY INJ. VIAL+SWFI 56 Cefpodoxime (200 Mg) + Pot..Clavuanate (125 Mg) DRUG TABLET 10X10 ALU ALU /STRIP 57 Cefpodoxime Proxetil -100 Mg DRUG TABLET 10X10 ALU-ALU 58 Cefpodoxime Proxetil -200 Mg DRUG TABLET 10X10 ALU-ALU 59 Cefpodoxime Proxetil 200Mg+ Ofloxacin 200Mg DRUG TABLET 10X10 ALU-ALU 60 Cefpodoxime Proxetil 25Mg DRUG DROPS 30 ML 61 Cefpodoxime Proxetil 50 Mg DRUG TABLET 10X10 ALU-ALU 62 Cefpodoxime Proxetil-100 Mg DRUG DRY SYP 30 ML 63 Cefpodoxime Proxetil-50 Mg+Clavulanic Acid31.25 Mg DRUG DRY SYP 30 ML+WATER 64 Cefpodoxime Proxetil-50 Mg+Clavulanic Acid Mg DRUG DRY SYP 30 ML 65 Cefpodoxime Proxetil-50Mg DRUG DRY SYP 30 ML 66 Ceftazidime + Tazobactam 1.125Mg DRUG DRY INJ. VIAL+SWFI 67 Ceftazidime + Tazobactam Mg DRUG DRY INJ. VIAL+SWFI 68 Ceftazidime 1000Mg DRUG DRY INJ. VIAL+SWFI 69 Ceftazidime 250Mg DRUG DRY INJ. VIAL+SWFI 70 Ceftazidime 500Mg DRUG DRY INJ. VIAL+SWFI 71 Ceftriaxone + Sulbactam 1500Mg DRUG DRY INJ. VIAL+SWFI 72 Ceftriaxone + Sulbactam 375Mg DRUG DRY INJ. VIAL+SWFI 73 Ceftriaxone + Sulbactam 750Mg DRUG DRY INJ. SVIAL+SWFI 74 Ceftriaxone + Tazobactam 1125Mg DRUG DRY INJ. VIAL+SWFI 75 Ceftriaxone + Tazobactam Mg DRUG DRY INJ. VIAL+SWFI 76 Ceftriaxone + Tazobactam Mg DRUG DRY INJ. VIAL+SWFI 77 Ceftriaxone 1000Mg DRUG DRY INJ. VIAL+SWFI 78 Ceftriaxone 125Mg DRUG DRY INJ. VIAL+SWFI 79 Ceftriaxone 250Mg DRUG DRY INJ. VIAL+SWFI 80 Ceftriaxone 500Mg DRUG DRY INJ. VIAL+SWFI 81 Cefuroxime 125Mg DRUG DRY SYP 30 ML 82 Cefuroxime 1500Mg DRUG DRY IN. SVIAL+SWFI
4 SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 83 Cefuroxime 750Mg DRUG DRY INJ. VIAL+SWFI 84 Cefuroxime Axetil DRUG TABLET 10X10 ALU-ALU 85 Cefuroxime Axetil DRUG TABLET 10X10 ALU-ALU 86 Ciprofloxacin 250Mg DRUG TABLET 10X10 ALU-ALU 87 Ciprofloxacin 500Mg DRUG TABLET 10X10 ALU-ALU 88 Clindamycin--300Mg DRUG CAPSULE 10X10 ALU-ALU 89 Gamifloxacin 320Mg DRUG TABLET 10X10 ALU-ALU 90 Imipenem + Cilastatin 250Mg DRUG DRY INJ. VIAL+SWFI 91 Imipenem + Cilastatin 500Mg DRUG DRY INJ. VIAL+SWFI 92 Levofloxacin 250Mg DRUG TABLET 10X10 BLISTER 93 Levofloxacin 500Mg DRUG TABLET 10X10 BLISTER 94 Linezolid-600 DRUG TABLET 10X10 ALU-ALU STRIP 95 Meropenem 100Mg DRUG DRY INJ. VIAL+SWFI+TRAY 96 Meropenem 125Mg DRUG DRY INJ. VIAL+SWFI+TRAY 97 Meropenem 250Mg DRUG DRY INJ.VIAL+SWFI+TRAY 98 Meropenem 500Mg DRUG DRY INJ. VIAL+SWFI+TRAY 99 Ofloxacin 200 Mg+Ornidazole 500 Mg+Lb 120 Million Spores+Sacchormyces Boulardii 2 Million Spores DRUG TABLET 10X10 BLISTER 100 Ofloxacin 200Mg DRUG TABLET 10X10 ALU-ALU 101 Ofloxacin 200Mg + Ornidazole 500Mg DRUG TABLET 10X10 ALU-ALU 102 Ofloxacin 400Mg DRUG TABLET 10X10 BLISTER 103 Piperacillin + Tazobactam 1125Mg DRUG DRY INJ. VIAL+SWFI+TRAY 104 Piperacillin + Tazobactam 2250Mg DRUG DRY INJ. VIAL+SWFI+TRAY 105 Piperacillin + Tazobactam 4500Mg DRUG DRY INJ. VIAL+SWFI+TRAY 106 Prulifloxacin 600Mg DRUG TABLET 10X10 ALU-ALU 107 Roxythromycin 150Mg DRUG TABLET 10X10 ALU-ALU 108 Sparfloxacin-200 DRUG TABLET 10X10 ALU-ALU Manufacturer for most of the multinational companies in india (3rd Party Manufacturing) Healthcare WANBURY UNIMARK REMEDIES GALPHA LABORATORIES LTD Pharmaceuticals Ltd.
5 Contact us Contact Persons : Gurjeet Kaur Sales Manager Mob gurjeet@gmh.co.in Preeti Malhotra Sales Manager Mob trade@xieonlife.com Jayant Verma Sales Executive Mob business@gmhlaboratories.com Xieon Life Sciences Pvt Ltd Corporate off (I):-Plot No-171, Sec-3, HSIIDC, Industrial Area, Karnal (Haryana) GMH
Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules
KAPL list of products applicable for Institutional/Hospital supplies under Pharmaceuticals Purchase Policy (PPP) issued by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India
EUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
+91-8071676073 Grapple Life Sciences Private Limited http://www.grapplelifesciences.com/ Our organization is engaged in the supplying, wholesaling, trading and service providing of Pharmaceutical Medicine.
INJECTION GMP FSC AMPICILLIN SODIUM 500mg/1 g+ SULBACTAM DRY POWDER INJECTION GMP FSC
1 S.NO COMPOSITION DOSAGE FORM PLANT CERTIFICATION DOCUMENTS 1 AZITHROMYCIN 500mg AMOXYCILLIN 250mg/500 mg/1 g+ POTASSIUM 2 CLAVULANIC 50mg/100mg/200mg AMPICILLIN SODIUM 500mg/1 g+ SULBACTAM 3 250mg/0.5g
I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.
Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
Routine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
- the details, where possible, of the antibiotic products these companies supply or have supplied.
Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal
Compliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
PRODUCT-LIST KENVISH HEALTHCARE
PRODUCT-LIST TABLETS SR. PRODUCT COMPOSITION PACK PKING 1 Exopan-40 PANTAPRAZOLE 40 MG 2 Exopan-D PANTAPRAZOLE 40 MG+DOMPERIDONE 10 MG 3 Kenvizole-20 RABEPRAZOLE 20 MG 4 Kenvizole-D RABEPRAZOLE 20 MG+DOMPERIDONE
ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio
ANTIBIOTICS Orbit s ANTIBIOTICS Portfolio ANTIBIOTICS Antibiotics (from ancient Greek αντιβιοτικά, antibiotiká), also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention
AMR Industry Alliance Antibiotic Discharge Targets
AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge
Contact Number: S. NO. BRAND COMPOSITION STRENGTH PACKING Dec-25 Nandrolone Decanoate 25mg Single Dispo Pack 1
Registered Address: #376 Ground, Ist Floor,Vill Saketri, District-Panchkula- 134109 Marketing Office: #1027,Manimajra,First Floor,Motor Market,Chandigarh, 160101 Contact Number: 9041091840 Email address:
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
WELCOME TO ZAVIK DRUGS PVT LTD ZAVIK DRUGS PVT LTD. SCO.353, MOTOR MARKET, 1 ST & 2 ND FLOOR, MANIMAJRA, CHANDIGARH PH
1 WELCOME TO ZAVIK DRUGS PVT LTD ZAVIK DRUGS PVT LTD. SCO.353, MOTOR MARKET, 1 ST & 2 ND FLOOR, MANIMAJRA, CHANDIGARH PH. 7814616006 2 TABLETS AND CAPSULE PRODUCTS COMPOSITION PACKIN G AAVIK-P AAVIK-SP
2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
ALICIA HEALTHCARE 1st Floor Bansal Honda Automobile Near Pnb Bank Vpo. & Teh. Bilaspur Distt. Yamunanager (H.R)
ALICIA HEALTHCARE 1st Floor Bansal Honda Automobile Near Pnb Bank Vpo. & Teh. Bilaspur Distt. Yamunanager (H.R)-135102 MOB. 7419087312, 13 E-Mail-aliciahealthcare1@gmail.com TABLETS No. Brand Name Composition
TABLETS 01 AZITRO-250 Azithromycin 250mg Tablet 10*6 Blister 02 AZITRO-500 Azithromycin 500mg Tablet 10*3 Blister
Dated 1/07/2018 S.N0 PRODUCT COMPOSITIONS PACKING TYPE STYLE TABLETS 01 AZITRO-250 Azithromycin 250mg 10*6 Blister 02 AZITRO-500 Azithromycin 500mg 10*3 Blister 03 GLUTRO-GM Diacerin 50mg+Glucosamine Sulphate
2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
Fedley healthcare Pvt. Ltd.
Fedley healthcare Pvt. Ltd. (An ISO 9001:2008 Certified Company) S.C.F. - 495, 1st. Floor, Motor Market, Manimajra -160101, Chandigarh. Contact nos.: 098886-56719, 09467946767 Email: fedleycare@gmail.com
Compliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
What s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
PCD List ( Biotech Drugs )
PCD List ( Biotech Drugs ) INJECTION S.N. BRAND NAME COMPOSITION PACKING 1 NEONEM-1G Meropenem IP 1g 1X20ml 2 TAPIP-4.5 Piperacillin 4000+Tazobactum 500 1X20ml 3 TOPIN-1G Cefotaxime Sodium IP 1g 1X10ml
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix O 3 December 2014 Final version Commissioned
GENEDA PHARMA SCO 496 SECOND FLOOR, MOTOR MARKET, MANIMAJRA, CHANDIGARH. PIN mail: no :
GENEDA PHARMA SCO 496 SECOND FLOOR, MOTOR MARKET, MANIMAJRA, CHANDIGARH. PIN 160101 mail: genedapharma@gmail.com no : 9780585039 BRAND NAME COMPOSITION 1 CICLOGEN-P ACECLOFENAC 100MG + PARACETAMOL 325MG
GOBIERNO DE PUERTO RICO Administración de Servicios Médicos de Puerto Rico
1 Acetylcysteine Solution 20% Vial 10ml 2 Acetylcysteine Solution 20% Vial 30ml 3 Activated Charcoal Bottle 4 fl oz or 8 fl oz 4 Adenosine 6mg/2ml Inj Solution Syringe / Vial 2ml 5 Albuterol Sulfate Inhalation
January 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
GENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
January 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
Welcome to MK Medicine
S.no. Composition Packing 1 Aceclofenac 100 mg Paracetamol 325 mg Chlorzoxazone 250 mg 2 Aceclofenac 100 mg Paracetamol 325 mg Serratiopeptidase 15 mg ( / Blister) 3 Aceclofenac 100 mg Paracetamol 325
S. NO. BRAND COMPOSITION STRENGTH PACKING. Adic Inj. Diclofenac Sodium Inj. 25mg/ml Tray Pack (10x3ml)
Registered Address: #376 Ground, Ist Floor,Vill Saketri, District-Panchkula- 134109 Contact Number: 8699028993 ; 9646001840 Email address: pankaj.altiuslifescience@ultrahealthcare.in Adic Inj. Diclofenac
Antibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
Antimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
S.NO BRAND NAME COMPOSITION PACKING. 1 PHENUS-P Aceclofenac 100mg+Paracetamol 325mg(BLISTER) 10*10
S.NO BRAND NAME COMPOSITION PACKING 1 PHENUS-P Aceclofenac 100mg+Paracetamol 325mg(BLISTER) 10*10 2 PHENUS-P Aceclofenac 100mg+Paracetamol 325mg(Alu-Alu) 10*10 3 PHENUS-SP 4 PHENUS-MR Aceclofenac 100mg+paracetamol
OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials
Clinical Monitoring of Outpatient Parenteral Antimicrobial Therapy (OPAT) and Selected Oral Antimicrobial Agents Adult Inpatient/Ambulatory Clinical Practice Guideline Appendix A. Coordinating an OPAT
Contact Number: ; address: ;
Registered Address: #376 Ground, Ist Floor,Vill Saketri, District-Panchkula- 134109 Marketing Office: #1027,Manimajra,First Floor,Motor Market,Chandigarh, 160101 Contact Number: 8699028993; 8872186622
Artemether 80mg+Lumefantrine 480mg Tablets (Monocartoon Packing)
SKYWELL HEALTHCARE PVT. LTD. (AN ISO 9001:2015 CERTIFIED COMPANY) SCF 331, Ground Floor, Motor Market,Manimajra(Chandigarh) Email I.D: Skywellhealthcare@gmail.com, Contact No.:09592-172172, 09592-182182
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India
Human Journals Research Article April 2016 Vol.:6, Issue:1 All rights are reserved by Zarine Khety et al. Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Keywords: Drug
Anti-infection Agents
Pisutam (Lyo) Lyo for Inj. 2.25g 1 Pisutam (Lyo) Lyo for Inj. 4.5g 1 Pisutam Pow. for Inj. 2.25g 1 Pisutam Pow. for Inj. 4.5g 2 Picillina Pow. for Inj. 2g 2 Picillina Pow. for Inj. 4g 2 Ocillina Pow. for
1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
Antimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...
SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline
Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
Available online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
Lines: , (fax) I S. No. Product Name Composition Pack Pack Type MRP TABLETS
1 ARTIVA LM Tab Artimether 80mg + Lumefantrine 480 mg 10*1*6 Alu-Alu Mono Pack 165.00 2 AZIROCIN 250 Tab Azithromycin 250mg 10*1*6 Blister Mono Pack 64.00 3 AZIROCIN 500 Tab Azithromycin 500mg 10*1*3 Blister
56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health
YOUR PREFERRED PARTNER IN QUALITY HEALTH CARE For better health Manufacturer of Pharmaceutical Products Eka Pharma 308, Samanvay Zillion, Gotri - Sevasi Road, Opp. Shaishav School, Vadodara-391 101, (Guj.)
Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
Copyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at
Malignant Otitis Externa Inflammation and damage at the base of the skull due to an untreated outer ear P. aeruginosa most common organism Yellow-green drainage from the ear Odor Fever Deep inner ear pain
2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #116 (NQF 0058): Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
Discussion Points. Decisions in Selecting Antibiotics
Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical
PRICE LIST W.E.F. 7 JULY,2017 PRODUCT Generic Name SHIPPER Minimum Packing Tablets & capsules
PRIMUS PHARMACEUTICALS SADHOURA ROAD, MOUZA: OGLI KHARI VILLAGE: ASGARPUR MAJRA, KALA AMB, DISTT: SIRMOUR(H.P) E.Mail : primuspharmaceuticals@gmail.com PRICE LIST W.E.F. 7 JULY,2017 PRODUCT Generic Name
Antibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007
Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007 1 Ongoing data from CDC 's Gonococcal Isolate Surveillance Project (GISP), including
Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections
Vol.1 No.2 Oct-Dec 2013 ISSN : 2321-6387 Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections S. Yogeshpriya*, Usha N.Pillai, S. Ajithkumar and N. Madhavan Unny Department
Childrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
CONCORD DRUGS LIMITED Hyderabad
CONCORD DRUGS LIMITED Hyderabad Product List (Injectables) Tissue Bio Adhesive Product Name Packing Strength/ Each Ampoule Therapeutic use Iso Amyl 2-Cyano Acrylate Ampoule 0.25, 0.50 and 1.0 ml. Bio-Adhesive
3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on
The Good Antibiotics: the Good, the Bad and the Ugly John P. Cello, MD Professor of Medicine and Surgery, University of California, San Francisco Most organisms can be readily identified by culture, special
Registered Drug Product List:
354 Aguirre Ave. Phase III BF Homes Parañaque City, Metro Manila Philippines +63 2 829 7294/ 826 4902 +63 2 820 4151 Email: info@saharint.com / private_2ii@hotmail.com Antibiotic Line Products: 1 P age
https://www.indiamart.com/healthbiotech/
+91-8079454100 Health Biotech Limited https://www.indiamart.com/healthbiotech/ The top most leading manufacturing company offers best quality range of broad portfolio of finished Pharmaceutical Formulations.
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
S.NO COMPOSITION PACKING TABLETS & CAPSULES
S.NO COMPOSITION PACKING TABLETS & CAPSULES 1 Aceclofenac 100mg+Paracetamol 325mg(BLISTER) 10*10 2 Aceclofenac 100mg+Paracetamol 325mg(Alu-Alu) 10*10 3 Aceclofenac 100mg+paracetamol 325mg+serratiopeptidase
ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems
β-lactams ß-lactams Sub-families Penicillins Cephalosporins Monobactams Carbapenems ß-lactams Mode of action PBPs = Trans/Carboxy/Endo- peptidases PBP binding (Penicillin-Binding Proteins) activation of
Practical Notes on Antibiotics
Practical Notes on Antibiotics 1. Gram +ve bacteria Streptococci Staphylococci Gram +ve 2. Gram ve bacteria E-Coli Pseudomonas Gram -ve 3. Atypical organisms Mycoplasma, Chalmydia Classification of bacteria
Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
Bureau of Laboratory Quality Standards Page 1 of 10
1. Ceftriaxone sodium sterile - Cef-3 Inj. (250-IM) - Cef-3 Inj. (250-IV) - Cef-3 Inj. (500-IM) - Cef-3 Inj. (500-IV) - Cef-3 Inj. (1 g -IM) - Cef-3 Inj. (1 g IV) - Cef-3 Inj. (2 g IV) 2. Ceftazidime pentahydrate
H.L. HEALTHCARE PVT. LTD.
H.L. HEALTHCARE PVT. LTD. CONTACT DETAIL :- H.L. HEALTHCARE PVT. LTD. SCF-320, IST FLOOR, MOTOR MARKET,, CHANDIGARH-160 101 (UT) For Franchisee query - Miss Jaskiran PH. 9216230025, Toll Free Number: 1800
Approach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
ARUNABH PHARMA Pvt. Ltd. COMMITTED FOR GOOD HEALTH & QUALITY PRODUCTS An ISO 9001:2000 Certified Products
ARUNABH PHARMA IN PRODUCTS LIST ANTIBIOTICS NO. PRODUCTS Product Composition T.C.S.I TYPES PACK M.R.P 1 AMOXYTEK-CV 625 Amoxyclin 500 mg. + Clavulanic Acid 125 mg. CAPS BLISTER 10X6 1194.00 2 AMOXYTEK-CV
Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate Use of Healthcare 2019 COLLECTION
No /46/2016-PI.I GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS
No. 31015/46/2016-PI.I GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS.. A- Wing, Shastri Bhawan, New Delhi 110 001 Subject: Review application of M/s Cipla Ltd. against
Secondary peritonitis
Secondary peritonitis Caused by spillage of gastrointestinal microorganisms into the peritoneal cavity secondary to loss of the integrity of the mucosal barriers Etiology: perforation of peptic ulcer traumatic
Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
Hospital-Acquired Pneumonia (2009)
Hospital-Acquired Pneumonia (2009) Philippine Hospital Infection Control Society (PHICS) 2nd Floor, PSMID Bldg., 116 9th Avenue, Cubao, Quezon City Telephone o.: 913-2852 Fax o.: 687-1198 E-mail: phicsinc@yahoo.com
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS FINAL November 29, 2017 Working Group: Joanne Langley (Chair),
DOCTRIS LIFE SCIENCES
DOCTRIS LIFE SCIENCES AN ISO 9001:2015 CERTIFIED COMPANY SCF-513, 1st FLOOR, MOTOR MARKET, MANIMAJRA, CHANDIGARH- 160101 EMAIL ID:-doctrislifesciences@gmail.com Mo. -+919779328069 +919041100915 TABLETS
Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes
Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi
The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
Fluoroquinolones in 2007: the Angels, the Devils, and What Should the Clinician Do?
Fluoroquinolones in 2007: the Angels, the Devils, and What Should the Clinician Do? David C. Hooper, M.D. Division of Infectious Diseases Infection Control Unit Massachusetts General Hospital Harvard Medical
Liofilchem. ID-AST systems
Liofilchem ID-AST systems Systems for ID and AST directly from clinical specimens page 1 Integral Systems for ID and AST from isolated colonies page 4 Systems for ID from isolated colonies page 6 Systems
ANNEXURE I. Schedule - I DRUG CONSUMPTION PROFILE
i ANNEXURE I Schedule - I DRUG CONSUMPTION PROFILE 1. Name: 2. Sex: [1.] Male [2.] Female 3. Age: 4. Economic status/occupation: 5. Name of the village: 6. Type of Hospital: [1.] Retail Pharmacy outlet
Vibrio vulnificus. Vibrio vulnificus V. vulnificus. pectinata japonica)
2006 1 Vibrio vulnificus 1 1) 1) 1) 2) 1) 1) 2) 17 5 16 17 11 17 Vibrio vulnificus V. vulnificus 7 9 11 79 2004 11 14 (Atrina pectinata japonica) 3 11 17 16 A B 20 11 17 V. vulnificus 7 9 11 Key words:
Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products
Quality of 2 nd line medicines for tuberculosis Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products Case studies in medicines for tuberculosis Outline: Statistics
Anti-infection Agents
Supecef Pow. for Inj. 0.5g 1 Supecef Pow. for Inj. 1g 1 Cefuroxime Pow. for Inj. 750mg 1 Tatumcef Pow. for Inj 0.5g 2 Tatumcef Pow. for Inj 1g 2 Tatumcef Pow. For Inj. 2g 2 Cefazolin Injection 1g 3 Pisutam
Antimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate
(AN ISO 9001 : 2008 CERTIFIED COMPANY)
H.O.:DSS-19, Sector-8, Huda Market KARNAL-132001(Haryana) 0184-4036667 (AN ISO 9001 : 2008 CERTIFIED COMPANY) Price List W.E.F. 01/05/14. Sr.No. Product Name Tablets Mob.: +91 99922 22020. Email i.d.:
Int. J. Pharm. Sci. Rev. Res., 28(2), September October 2014; Article No. 06, Pages: 28-34
Research Article A Study on Evaluation of Appropriateness of Antibiotics Used in the Intensive Care Unit Settings of a Tertiary Care Teaching Hospital Balaji S 1, Karthik S 2, Madhuri Pasupuleti 3, G Kannan*
2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY
Canadian Nosocomial Infection Surveillance Program 2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY FINAL Working Group: E. Henderson, M. John, I. Davis, S. Dunford,